Earnings · China A-shares
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Class A (600196) earnings
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Class A published its Q3 report on 2026-10-27: net profit +5.71% year on year, +8.42% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved -0.40% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-27
- Period end
- 2026-09-30
- Net profit YoY
- +5.71%
- Excl. one-offs YoY
- +8.42%
- Net profit QoQ
- +11.21%
- Result
- Neutral
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +1.14% | — |
| 3 days | -0.40% | — |
| 7 days | +4.00% | — |
| 14 days | -1.85% | — |
Report history
Over the last 8 reports, net profit grew year on year in 8 of them. The stock rose in the 3 trading days after 4 of 8 reports (average +1.21%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-28 | ¥2.67B | +5.71% | +8.42% | +3.64% | 1.01 | 5.42% | -0.40% | — | — |
| 2026 interim report | 2026-08-26 | ¥1.72B | +1.15% | +19.09% | +4.75% | 0.65 | 3.53% | -0.65% | +1.09% | +8.08% |
| 2026 Q1 report | 2026-04-29 | ¥870.83M | +13.87% | +21.96% | +6.93% | 0.33 | 1.78% | -2.09% | -11.62% | -12.57% |
| 2025 annual report | 2026-03-25 | ¥3.37B | +21.69% | +1.12% | +1.45% | 1.27 | 7.03% | +7.49% | +4.44% | -6.42% |
| 2025 Q3 report | 2025-10-29 | ¥2.52B | +25.50% | -14.32% | -4.91% | 0.95 | 5.30% | +2.06% | -4.05% | -0.58% |
| 2025 interim report | 2025-08-27 | ¥1.70B | +38.96% | -23.39% | -4.63% | 0.64 | 3.58% | +1.02% | +0.18% | -3.60% |
| 2025 Q1 report | 2025-04-30 | ¥764.76M | +25.42% | -32.56% | -7.26% | 0.29 | 1.61% | -0.04% | +6.84% | +3.67% |
| 2024 annual report | 2025-03-26 | ¥2.77B | +16.08% | +15.10% | -0.80% | 1.04 | 5.90% | +2.26% | -4.69% | -2.12% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.